Reactive arthritis (ReA) develops after an infection elsewhere in the body, generally in the genitourinary or intestinal tract. Chlamydia trachomatis, Yersinia enterocolitica, salmonella, shigella, and campylobacter are frequent triggering agents. Between 60% and 90% of patients are positive for HLA-B27. The arthritis occurs within 4 weeks of the primary infection and is oligoarticular and asymmetric. Extra-articular manifestations include mucocutaneous symptoms, ocular inflammation, and urethritis. The average duration of arthritis is 4 to 5 months but two-thirds of patients have symptoms for more than a year. Bacterial antigens have been found in synovial specimens from patients with ReA, but cultures are sterile. The treatment of ReA comprises non-steroidal anti-inflammatory drugs, intra-articular steroid injections, and physical treatment. Short-term antibiotic treatment has no effect in manifest ReA, whereas a tendency to improvement has been seen with treatment over months, at least after chlamydia infection.
HorowitzSHorowitzJTaylor-RobinsonDUreaplasma urealyticum in Reiter's syndrome. J Rheumatol1994;21:877–82.
9.
BraunJLaitkoSTreharneJChlamydia pneumoniae—a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis1994;53:100–5.
10.
CooperSMFerrissJA.Reactive arthritis and psittacosis. Am J Med1986;81:555–7.
11.
CopeAAndersonJWilkinsE.Clostridium difficile toxin-induced reactive arthritis in a patient with chronic Reiter's syndrome. Eur J Clin Microbiol Infect Dis1992;11:40–3.
12.
ShawRAStevensMB.The reactive arthritis of giardiasis. A case report. JAMA1987;258:2734–5.
13.
HayEMWinfieldJMcKendrickMW.Reactive arthritis associated with cryptosporidium enteritis. BMJ1987;295:248–9.
14.
WeyandCMGoronzyJJ.Immune responses to Borrelia burgdorferi in patients with reactive arthritis. Arthritis Rheum1989;32:1057–646.
15.
HassanWOldhamR.Reiter's syndrome and reactive arthritis in health care workers after vaccination. BMJ1994;309:94.
16.
BuskilaDGladmanD.Musculoskeletal manifestations of infection with human immunodeficiency virus. Rev Infect Dis1990;12:223–35.
17.
BermanAEspinozaLRDiazJDRheumatic manifestations of human immunodeficiency virus infection. Am J Med1988;85:59–64.
18.
WinchesterRBernsteinDHFischerHDEnlowRSolomonG.The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med1987;106:19–26.
19.
ForsterSMSeifertMHKeatACInflammatory joint disease and human immunodeficiency virus infection. BMJ1988;296:1625–7.
LochtHKihlströmELindströmFD.Reactive arthritis after salmonella among medical doctors—study of an outbreak. J Rheumatol1993;20:845–8.
22.
Leirisalo-RepoMSkylvGKousaM.Follow-up study of Reiter's disease and reactive arthritis. Factors influencing the natural course and the prognosis. Clin Rheumatol1987;6(Suppl 2):73–82.
23.
HannuTJLeirisalo-RepoM.Clinical picture of reactive salmonella arthritis. J Rheumatol1988;15:1668–71.
24.
SilveiraLHGutiérrezFScopelitisECuéllarMLCiteraGEspinozaLR.Chlamydia-induced reactive arthritis. Rheum Dis Clin North Am1993;19:351–62.
25.
FrydénABengtssonAFobergUEarly antibiotic treatment of reactive arthritis associated with enteric infections: Clinical and serological study. BMJ1990;301:1299–302.
26.
Leirisalo-RepoMSuorantaH.Ten-year followup study of patients with Yersinia arthritis. Arthritis Rheum1988;31:533–6.
MarsalLWinbladSWollheimFA.Yersinia enterocolitica arthritis in southern Sweden: A four-year follow-up study. BMJ1981;283:101–3.
29.
GranforsKOgasawaraMHillJLLahesmaa-RantalaRToivanenATak YanYu D.Analysis of IgA antibodies to lipopolysaccharide in Yersinia-triggered reactive arthritis. J Infect Dis1989;159:1142–7.
30.
Mäki-IkolaOLeirisalo-RepoMKanteleAToivanenPGranforsK.Salmonella-specific antibodies in reactive arthritis. J Infect Dis1991;164:1141–8.
31.
Hoogkamp-KorstanjeJAAde KoningJHeesemannJFestenJJMHoutmanPMvan OyenPLM.Influence of antibiotics on IgA and IgG response and persistence of Yersinia enterocolitica in patients with yersinia-associated spondylarthropathy. Infection1992;20:53–7.
32.
de KoningJHeesemannJHoogkamp-KorstanjeJAAFestenJJMHoutmanPMvan OyenPLM.Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: Correlation with specific serum IgA antibodies. J Infect Dis1989;159:109–12.
33.
KingsleyGPanayiG.Antigenic responses in reactive arthritis. Rheum Dis Clin North Am1992;18:49–66.
34.
GranforsKJalkanenSLindbergAASalmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet1990;335:685–8.
35.
GranforsKJalkanenSvon EssenRYersinia antigen in synovial-fluid cells from patients with reactive arthritis. N Engl J Med1989;320:216–21.
36.
NikkariSMerilahti-PaloRSaarioRYersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens. Arthritis Rheum1992;35:682–7.
37.
KeatAThomasBDixeyJOsbornMSonnexCTaylor-RobinsonD.Chlamydia trachomatis and reactive arthritis: The missing link. Lancet1987;i:72–4.
38.
Taylor-RobinsonDGilroyCBThomasBJKeatACS.Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet1992;340:81–2.
39.
RahmanMILCheemaMASchumacherHRHudsonAP.Molecular evidence for the presence of Chlamydia trachomatis in the synovium of patients with Reiter's syndrome. Arthritis Rheum1992;35:521–9.
40.
PooleESHightonJWilkinsRJLamontIL.A search for Chlamydia trachomatis in synovial fluids from patients with reactive arthritis using the polymerase chain reaction and antigen detection methods. Br J Rheumatol1992;31:31–4.
41.
HermannE.T cells in reactive arthritis. APMIS1993;101:177–86.
HammerREMaikaSDRichardsonJATangJPTaurogJD.Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human B2m: An animal model of HLA-B27-associated human disorder. Cell1990;63:1099–112.
44.
Taylor-RobinsonD.Laboratory methods for chlamydia infections. J Infection1992:25(Suppl 1):61–7.
45.
SieperJBraunJReichardtMEggensU.The value of specific antibody detection and culture in the diagnosis of reactive arthritis. Clin Rheum1993;12:245–52.
46.
Leirisalo-RepoM.Are antibiotics of any use in reactive arthritis?APMIS1993;101:575–81.
47.
BardinTEnelCCornellsFAntibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum1992;35:190–4.
48.
PopertAJGillAJLairdSM.A prospective study of Reiter's syndrome: An interim report on the first 82 cases. Br J Vener Dis1964;40:160–5.
49.
PanayiGSClarkB.Minocycline in the treatment of patients with Reiter's syndrome. Clin Exp Rheumatol1989;7:100–1.
50.
PottHGWittenborgAJunge-HülsingG.Long-term antibiotic treatment in reactive arthritis. Lancet1988;i:245–6.
51.
LauhioALeirisalo-RepoMLähdevirtaJSaikkuPRepoH.Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to chlamydia arthritis. Arthritis Rheum1991;34:6–14.
52.
ToivanenAYli-KerttulaTLuukkainenRMerilahti-PaloRGranforsKSeppalaJ.Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol1993;11:301–7.
